Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1977;4(Suppl 2):69S–75S. doi: 10.1111/j.1365-2125.1977.tb05762.x

A comparative review of the pharmacology of nomifensine

Irmgard Hoffmann
PMCID: PMC1429114  PMID: 911654

Abstract

1 Nomifensine is a new substance which showed, in tests for antidepressant activity, a pronounced effect which is quantitatively better than that of the reference substances.

2 With regard to thymoleptic effects in animal studies the effect of nomifensine is similar to that of tricyclic antidepressants, but nomifensine has no pronounced anticholinergic activity.

3 Nomifensine influences the cardiovascular system very slightly.

4 The mechanism of action of nomifensine differs from that of tricyclic antidepressants and must be clearly differentiated from phenylalkyl amines with sympathomimetic activity.

5 Nomifensine is a compound with a special, new profile of action, and thus cannot be classified in known categories.

Full text

PDF
69S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Costall B., Kelly D. M., Naylor R. J. Nomifensine: a potent dopaminergic agonist of antiparkinson potential. Psychopharmacologia. 1975;41(2):153–164. doi: 10.1007/BF00421073. [DOI] [PubMed] [Google Scholar]
  2. Costall B., Naylor R. J. A comparison of circling models for the detection of antiparkinson activity. Psychopharmacologia. 1975;41(1):57–64. doi: 10.1007/BF00421307. [DOI] [PubMed] [Google Scholar]
  3. Costall B., Naylor R. J. Actions of dopaminergic agonists on motor function. Adv Neurol. 1975;9:285–297. [PubMed] [Google Scholar]
  4. Costall B., Naylor R. J., Pycock C. The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine. J Pharm Pharmacol. 1975 Dec;27(12):943–946. doi: 10.1111/j.2042-7158.1975.tb10253.x. [DOI] [PubMed] [Google Scholar]
  5. Gerhards H. J., Carenzi A., Costa E. Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum. Naunyn Schmiedebergs Arch Pharmacol. 1974;286(1):49–63. doi: 10.1007/BF00499104. [DOI] [PubMed] [Google Scholar]
  6. Hoffmann I. 8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline, a new antidepressant. Arzneimittelforschung. 1973 Jan;23(1):45–50. [PubMed] [Google Scholar]
  7. Hoffmann I., Ehrhart G., Schmitt K. 8-Amino-4-phenyl-1,2,3,4-tetrahydroisochinoline, eine neue Gruppe antidepressiver Psychopharmaka. Arzneimittelforschung. 1971 Jul;21(7):1045–1045. [PubMed] [Google Scholar]
  8. Maj J., Kapturkiewicz Z., Michaluk J. Uber die zentrale Wirkung von Nomifensin. Arzneimittelforschung. 1976;26(6):1109–1111. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES